AHR and thyroid gland carcinoma: Collectively, our data indicate the existence of the CYP2S1-AHR feedback loop, contributing to malignant phenotypes of BRAFV600E-driven thyroid cancers, and also make rationalization of the synthetic lethal interaction between CYP2S1 and BRAFV600E (Fig. 7a).